An observational study in Obesity and Obstructive Sleep Apnea, sponsored by Centre Hospitalier Universitaire Saint Pierre. Recruiting at 2 sites in Belgium. Open to participants aged 18 Years to 99 Years. Per ClinicalTrials.gov, last updated 2024-02-13.
Sponsored by Centre Hospitalier Universitaire Saint Pierre · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 133 studies in Obesity with a site in Belgium — 40 open to participants now, 56 under way, 22 of them phase 3. Obesity · Belgium.
Among the 133 studies in Obesity with a site in Belgium, this one is the 29th largest by planned enrollment of the 35 observational ones that give a count, is one of 7 that started in 2022, is one of 35 observational ones, reaches primary completion later than 18 of the 55 other live ones, and was the 82nd registered.
11,564 studies on the registry are indexed under Obesity; 2,063 are open to participants now.
Browse Obesity studies →40 of the 133 studies in Obesity with a site in Belgium are open now. Recruiting first, the newest first:
Eli Lilly and Company · Sites in Belgium, United States, Israel and 7 more countries
Ages 6–11
Universitaire Ziekenhuizen KU Leuven · Sites in Belgium
Ages 18–65
Novo Nordisk A/S · Sites in Belgium, United States, Bulgaria and 7 more countries
Ages 18+
Novo Nordisk A/S · Sites in Belgium, United States, Argentina and 16 more countries
Ages 18+
Université Catholique de Louvain · Sites in Belgium
Ages 18–65
A study can be open while its sites in Belgium have not opened yet or have stopped. Only those recruiting at a site in Belgium →
Of the 1,352 Obesity studies recruiting now, 382 (28%) set no upper age limit and 867 (64%) stop at 75 or younger; 169 take children under 18; 491 take healthy volunteers.
This study: 18 Years to 99 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
133 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 7 · Phase 2 10 · Phase 3 37 · Phase 4 10
First in 2001; this study’s year is marked. 7 started in 2022.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 60 is below the median of 115 across 2,159 observational studies indexed under Obesity.
Median enrollment 200 across the 97 interventional studies, 150 across the 35 observational. Of the 65 that completed or were terminated, 15 (23%) have results posted.
This tab as a report to print or save as PDF → With an account.
61 of 133 have an industry lead sponsor. The 10 most frequent:
Centre Hospitalier Universitaire Saint Pierre is the lead sponsor of 78 studies on the registry; 12 are open to participants now.
Centre Hospitalier Universitaire Saint Pierre has 3 studies filed under Obesity — fewer than ten, so there is no comparison to draw.
9 of the studies in Obesity with a site in Belgium that are under way reach primary completion within a year, 3 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06858839Phase 3AmgenEvaluation of Maridebart Cafraglutide in Adult Participants Without Type 2 Diabetes Mellitus Who Have Obesity or Are Overweight | 2027-01-21 |
| NCT06672549Phase 3Eli Lilly and CompanyA Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040) | 2027-02 |
| NCT05556512Phase 3Eli Lilly and CompanyA Study of Tirzepatide (LY3298176) on the Reduction on Morbidity and Mortality in Adults With Obesity | 2027-10 |
| NCT07145671Universiteit AntwerpenThe COCCOS Study: a Transition Program for Young Persons With Chronic Conditions | 2026-12 |
| NCT05315752Centre Hospitalier Universitaire Saint PierreChanges in Body Fat and Morphologic Characteristics Associated With OSA Resolution After Bariatric Surgery | 2026-12-31 |
Add all 9 to your calendar (.ics) → With an account.
Among the 133 studies in Obesity with a site in Belgium, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Prospective study with inclusion of bariatric surgery candidates with diagnosed Obstructive Sleep Apnea and requiring treatment with Continuous Positive Air Pressure, aiming to evaluate at 2-6-12 months after bariatric surgery whether the relationship between biometric changes (reduction in neck circumference, height, waist/hip ratio, and fat and lean mass) and the resolution of OSA is better than the relationship between these biometric changes and BMI reduction.
Investigators are concerned about the high prevalence of Obstructive Sleep Apnoea syndrome (OSA) in the bariatric population. Postoperatively, there is a high rate of recovery from OSA. Indeed, investigators know from previous reports that weight loss is a very effective, but time consuming, strategy for treating OSA. Patients are therefore treated with CPAP (Continuous Positive Airway Pressure) while waiting for weight loss. In a recent meta-analysis, which focused on the effect of weight loss achieved through lifestyle interventions in 618 overweight and obese patients, the apnea-hypopnea index (AHI) decreased by an amount of 16/h for an average weight loss of 14 kg (1). However, the majority of patients are not able to maintain weight loss in the long term, and weight gain is associated with recurrence/aggravation of OSAS (2). Nowadays, bariatric surgery is a common strategy to achieve sustained and significant weight loss in obese patients. Sarkhosh et al. examined the impact of bariatric surgery (restrictive procedures, with a mild malabsorption component, or largely malabsorptive procedures) on sleep apnoea in 13,900 patients. Depending on the procedure, improvement or resolution of OSAS was achieved in 78-90% of patients (3).
Prospective longitudinal postoperative follow-up study : inclusion of patients who had scheduled bariatric surgery, diagnosed with OSA, AHI > 15 (polysomnography), treated with self-controlled CPAP (APAP), under remote monitoring;
Baseline measures:
Follow-up:
Eligible patients from CHU St Pierre hospital setting
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Any informed person who is
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
BMI (body mass index)
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Bariatric surgery includes (but is not limited to) * Gastric bypass: surgical bypass of the entire stomach, duodenum and approximately 1 m of the proximal small intestine * Sleeve: a large part of the stomach is removed laparoscopically, the open vertical edges are put back in place to leave a sleeve-like tube. Bariatric surgery is considered a treatment option * for patients with a BMI \>40 kg/m 2 , assuming the patient has previously participated successfully in a group weight management programme (weight loss \>7%) or * for patients with a BMI of 35-40 kg/m 2 when the obesity is associated with type 2 diabetes or hypertension, or OAS (with CPAP therapy) or severe musculoskeletal disease
Comparison of (1) the relationship between waist circumference changes and resolution of obstructive sleep apnea and (2) the relationship between the changes in waist circumference and BMI
Comparison of (1) the correlation between waist circumference reduction and resolution of OAS (AHI\<10/hour on polysomnography) and (2) the correlation between waist circumference reduction and BMI reduction
Time frame: 2 months
Comparison of (1) the relationship between waist circumference changes and resolution of obstructive sleep apnea and (2) the relationship between the changes in waist circumference and BMI
Comparison of (1) the correlation between waist circumference reduction and resolution of OAS (AHI\<10/hour on polysomnography) and (2) the correlation between waist circumference reduction and BMI reduction
Time frame: 6 months
Comparison of (1) the relationship between waist circumference changes and resolution of obstructive sleep apnea and (2) the relationship between the changes in waist circumference and BMI
Comparison of (1) the correlation between waist circumference reduction and resolution of OAS (AHI\<10/hour on polysomnography) and (2) the correlation between waist circumference reduction and BMI reduction
Time frame: 12 months
Comparison of (1) the correlation between neck circumference reduction and OAS resolution and (2) the correlation between neck circumference reduction and BMI reduction
Comparison of (1) the correlation between neck circumference reduction and OAS resolution (AHI\<10/hour on polysomnography) and (2) the correlation between neck circumference reduction and BMI reduction
Time frame: 2 months
Comparison of (1) the correlation between neck circumference reduction and OAS resolution and (2) the correlation between neck circumference reduction and BMI reduction
Comparison of (1) the correlation between neck circumference reduction and OAS resolution (AHI\<10/hour on polysomnography) and (2) the correlation between neck circumference reduction and BMI reduction
Time frame: 6 months
Comparison of (1) the correlation between neck circumference reduction and OAS resolution and (2) the correlation between neck circumference reduction and BMI reduction
Comparison of (1) the correlation between neck circumference reduction and OAS resolution (AHI\<10/hour on polysomnography) and (2) the correlation between neck circumference reduction and BMI reduction
Time frame: 12 months
Comparison of (1) the correlation between hip circumference reduction and OAS resolution and (2) the correlation between hip circumference reduction and BMI reduction
Comparison of (1) the correlation between hip circumference reduction and OAS resolution (AHI\<10/hour on polysomnography) and (2) the correlation between hip circumference reduction and BMI reduction
Time frame: 2 months
Comparison of (1) the correlation between hip circumference reduction and OAS resolution and (2) the correlation between hip circumference reduction and BMI reduction
Comparison of (1) the correlation between hip circumference reduction and OAS resolution (AHI\<10/hour on polysomnography) and (2) the correlation between hip circumference reduction and BMI reduction
Time frame: 6 months
Comparison of (1) the correlation between hip circumference reduction and OAS resolution and (2) the correlation between hip circumference reduction and BMI reduction
Comparison of (1) the correlation between hip circumference reduction and OAS resolution (AHI\<10/hour on polysomnography) and (2) the correlation between hip circumference reduction and BMI reduction
Time frame: 12 months
Comparison of (1) the correlation between lean mass reduction and OAS resolution and (2) the correlation between lean mass reduction and BMI reduction
Comparison of (1) the correlation between lean mass reduction and OAS resolution (AHI\<10/hour on polysomnography) and (2) the correlation between lean mass reduction and BMI reduction
Time frame: 2 months
Comparison of (1) the correlation between lean mass reduction and OAS resolution and (2) the correlation between lean mass reduction and BMI reduction
Comparison of (1) the correlation between lean mass reduction and OAS resolution (AHI\<10/hour on polysomnography) and (2) the correlation between lean mass reduction and BMI reduction
Time frame: 6 months
Comparison of (1) the correlation between lean mass reduction and OAS resolution and (2) the correlation between lean mass reduction and BMI reduction
Comparison of (1) the correlation between lean mass reduction and OAS resolution (AHI\<10/hour on polysomnography) and (2) the correlation between lean mass reduction and BMI reduction
Time frame: 9 months
Started Apr 2022 (actual). Primary completion is estimated for Dec 2026, 56 months after the start.
Of 796 non-industry observational studies under Obesity, half reached primary completion within 40 months of starting (the median), counting those still running; a quarter within 17 and three quarters within 106. This study's planned 56 months is above that.
Counting every sponsor, half of 842 studies reached it within 39 months; a quarter within 17 and three quarters within 96.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Centre Hospitalier Universitaire Saint Pierre